Cargando…

Innovative Partnerships for the Elimination of Human African Trypanosomiasis and the Development of Fexinidazole

Human African Trypanosomiasis (HAT or sleeping sickness) is a life-threatening neglected tropical disease that is endemic in 36 sub-Saharan African countries. Until recently, treatment options were limited and hampered by unsatisfactory efficacy, toxicity, and long and cumbersome administration regi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neau, Philippe, Hänel, Heinz, Lameyre, Valérie, Strub-Wourgaft, Nathalie, Kuykens, Luc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157581/ https://www.ncbi.nlm.nih.gov/pubmed/32012658 http://dx.doi.org/10.3390/tropicalmed5010017

Ejemplares similares

Development and Introduction of Fexinidazole into the Global Human African Trypanosomiasis Program
por: Valverde Mordt, Olaf, et al.
Publicado: (2022)

Fexinidazole for Human African Trypanosomiasis, the Fruit of a Successful Public-Private Partnership
por: Bernhard, Sonja, et al.
Publicado: (2022)

Determination of an Optimal Dosing Regimen for Fexinidazole, a Novel Oral Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Studies
por: Tarral, Antoine, et al.
Publicado: (2014)

Product Development Partnerships: Delivering Innovation for the Elimination of African Trypanosomiasis?
por: Taylor, Emma Michelle, et al.
Publicado: (2020)

The European Medicines Agency’s scientific opinion on oral fexinidazole for human African trypanosomiasis
por: Pelfrene, Eric, et al.
Publicado: (2019)

Discovery, Development, Inventions and Patent Review of Fexinidazole: The First All-Oral Therapy for Human African Trypanosomiasis
por: Imran, Mohd, et al.
Publicado: (2022)

Efficacy and Toxicity of Fexinidazole and Nifurtimox Plus Eflornithine in the Treatment of African Trypanosomiasis: A Systematic Review
por: Hidalgo, Jessica, et al.
Publicado: (2021)

Modelling the impact of fexinidazole use on human African trypanosomiasis (HAT) transmission in the Democratic Republic of the Congo
por: Das, Aatreyee M., et al.
Publicado: (2021)

Safety and efficacy of oral fexinidazole in children with gambiense human African trypanosomiasis: a multicentre, single-arm, open-label, phase 2–3 trial
por: Kande Betu Kumesu, Victor, et al.
Publicado: (2022)

Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study
por: Kande Betu Ku Mesu, Victor, et al.
Publicado: (2021)

Pharmacokinetic-Pharmacodynamic Assessment of the Hepatic and Bone Marrow Toxicities of the New Trypanoside Fexinidazole
por: Watson, James A., et al.
Publicado: (2019)

The elimination of human African trypanosomiasis is in sight: Report from the third WHO stakeholders meeting on elimination of gambiense human African trypanosomiasis
por: Barrett, Michael P.
Publicado: (2018)

Is vector control needed to eliminate gambiense human African trypanosomiasis?
por: Solano, Philippe, et al.
Publicado: (2013)

A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease
por: Torrico, Faustino, et al.
Publicado: (2022)

Determinants of Human African Trypanosomiasis Elimination via Paratransgenesis
por: Gilbert, Jennifer A., et al.
Publicado: (2016)

Monitoring the elimination of human African trypanosomiasis: Update to 2016
por: Franco, José R., et al.
Publicado: (2018)

Monitoring the elimination of human African trypanosomiasis: Update to 2014
por: Franco, José R., et al.
Publicado: (2017)

Gambiense human African trypanosomiasis: the bumpy road to elimination
por: Hasker, Epco, et al.
Publicado: (2022)

Determination of the Optimal Single Dose Treatment for Acoziborole, a Novel Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Study
por: Tarral, Antoine, et al.
Publicado: (2023)

Monitoring the Progress towards the Elimination of Gambiense Human African Trypanosomiasis
por: Simarro, Pere P., et al.
Publicado: (2015)

Understanding the Role of the Diagnostic ‘Reflex’ in the Elimination of Human African Trypanosomiasis
por: Palmer, Jennifer J., et al.
Publicado: (2020)

Village-scale persistence and elimination of gambiense human African trypanosomiasis
por: Davis, Christopher N., et al.
Publicado: (2019)

First WHO Meeting of Stakeholders on Elimination of Gambiense Human African Trypanosomiasis
por: Holmes, Peter
Publicado: (2014)

Innovative digital technologies for quality assurance of diagnosis of human African trypanosomiasis
por: Hasker, Epco, et al.
Publicado: (2018)

African trypanosomiasis
por: Morrison, L J, et al.
Publicado: (2011)

Whose Elimination? Frontline Workers’ Perspectives on the Elimination of the Human African Trypanosomiasis and Its Anticipated Consequences
por: Falisse, Jean-Benoît, et al.
Publicado: (2020)

On the Road to Elimination of Rhodesiense Human African Trypanosomiasis: First WHO Meeting of Stakeholders
por: Holmes, Peter
Publicado: (2015)

Quantitative evaluation of the strategy to eliminate human African trypanosomiasis in the Democratic Republic of Congo
por: Rock, Kat S., et al.
Publicado: (2015)

Monitoring the elimination of human African trypanosomiasis at continental and country level: Update to 2018
por: Franco, José R., et al.
Publicado: (2020)

Fexinidazole interferes with the growth and structural organization of Trypanosoma cruzi
por: Zuma, Aline Araujo, et al.
Publicado: (2022)

Trypa-NO! contributes to the elimination of gambiense human African trypanosomiasis by combining tsetse control with “screen, diagnose and treat” using innovative tools and strategies
por: Ndung’u, Joseph Mathu, et al.
Publicado: (2020)

The history of African trypanosomiasis
por: Steverding, Dietmar
Publicado: (2008)

Immune trypanolysis test as a promising bioassay to monitor the elimination of gambiense human African trypanosomiasis
por: Dama, Emilie, et al.
Publicado: (2019)

WHO target product profiles: four diagnostic tests needed in the effort to eliminate African trypanosomiasis
por: Priotto, Gerardo, et al.
Publicado: (2023)

Eliminating Human African Trypanosomiasis: Where Do We Stand and What Comes Next>
por: Simarro, Pere P, et al.
Publicado: (2008)

Introducing the TrypanoGEN biobank: A valuable resource for the elimination of human African trypanosomiasis
por: Ilboudo, Hamidou, et al.
Publicado: (2017)

The elimination of human African trypanosomiasis: Achievements in relation to WHO road map targets for 2020
por: Franco, Jose R., et al.
Publicado: (2022)

Modelling to infer the role of animals in gambiense human African trypanosomiasis transmission and elimination in the DRC
por: Crump, Ronald E., et al.
Publicado: (2022)

An approach to the development of new drugs for African trypanosomiasis
Publicado: (1978)

Fexinidazole: A Potential New Drug Candidate for Chagas Disease
por: Bahia, Maria Terezinha, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_51nigt9ri6kfb8alk0lgc33dkf